BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Drug Development

  Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection

  Phase 3 HDV “D-LIVR” International Study Initiating

  December 18, 2018

   · 

  7 min read
• Pall Opens Center of Excellence in Shanghai

  Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China

  December 18, 2018

   · 

  2 min read
• Biotech Bay

  VITAS Healthcare Selects Oracle Cloud Applications to Optimize Its Workforce Management Systems

  VITAS Healthcare, a leading provider of end-of-life care in the US, has selected Oracle Cloud Applications to streamline core business and finance functions, anticipate and respond to frequently changing workforce needs, and support career success for nearly 12,000 VITAS employees.

  December 18, 2018

   · 

  2 min read
• Business

  Biocept and Prognos Enter Into Partnership to Apply Artificial Intelligence in Order to Help Pharmaceutical and Life Sciences Companies Optimize Commercialization of Biomarker-Targeted Therapies in Oncology

  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, has entered into a Software License and Laboratory Data Supply Agreement with Prognos, Inc.,

  December 18, 2018

   · 

  4 min read
• Business

  Context Therapeutics Announces Key Additions to its Board of Directors

  Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to the treatment of hormone-responsive cancers, today announced two key additions to its board of directors

  December 18, 2018

   · 

  5 min read
• Business

  Paula LeClair Joins Glytec as Executive Director and General Manager, Outpatient

  Glytec, the pioneer of digital therapeutics and leader in insulin optimization, welcomes Paula LeClair as Executive Director and General Manager, Outpatient. I

  December 18, 2018

   · 

  3 min read
• Job Trends

  MJardin Group Announces Medical Cannabis Research Investment in Spain

  MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, today announced its first medical cannabis research investment to fund two studies on the benefits of cannabinoids on epilepsy and schizophrenia.

  December 18, 2018

   · 

  5 min read
• Deals

  Apollo Endosurgery, Inc. Announces the Sale of Its Surgical Product Line

  Apollo Endosurgery, Inc., today announced the sale of its Surgical product line, which consists of the Lap-Band® adjustable gastric banding system and other accessories used in laparoscopic bariatric surgery, to ReShape Lifesciences Inc.

  December 18, 2018

   · 

  4 min read
• BioCapital

  The Starz Program Now Offering Franchise Opportunities Across The U.S.

  The Starz Program, a children’s fitness educational program, just announced it will offer franchise opportunities across the United States in 2019.

  December 18, 2018

   · 

  2 min read
• Biotech Beach

  OncoSec Announces Publication of New Research in the Journal Immunity Highlighting the Role of IL-12 in Anti-PD-1 Therapies with TAVO™ Directly Activating TILs in Patients

  “Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12" appears in the December 18, 2018 issue of Immunity

  December 18, 2018

   · 

  3 min read